Literature DB >> 24664870

Nemo-like kinase regulates postnatal skeletal homeostasis.

Ernesto Canalis1, Lauren Kranz, Stefano Zanotti.   

Abstract

Nemo-like kinase (Nlk) is related to the mitogen-activated protein (MAP) kinases and known to regulate signaling pathways involved in osteoblastogenesis. In vitro Nlk suppresses osteoblastogenesis, but the consequences of the Nlk inactivation in the skeleton in vivo are unknown. To study the function of Nlk, Nlk(loxP/loxP) mice, where the Nlk exon2 is flanked by lox(P) sequences, were mated with mice expressing the Cre recombinase under the control of the paired-related homeobox gene 1 (Prx1) enhancer (Prx1-Cre), the Osterix (Osx-Cre) or the osteocalcin/bone gamma carboxyglutamate protein (Bglap-Cre) promoter. Prx1-Cre;Nlk(Δ/Δ) mice did not exhibit a skeletal phenotype except for a modest increase in trabecular number and connectivity observed only in 3-month-old male mice. Osx-Cre;Nlk(Δ/Δ) male and female mice exhibited an increase in trabecular bone volume secondary to an increased trabecular number at 3 months of age. Bone histomorphometry revealed a decrease in osteoclast number and eroded surface in male mice, and decreased osteoblast number and function in female mice. Expression of osteoprotegerin mRNA was increased in calvarial extracts, explaining the decreased osteoclast and osteoblast number. The conditional deletion of Nlk in mature osteoblasts (Bglap-Cre;Nlk(Δ/Δ) ) resulted in no skeletal phenotype in 1- to 6-month-old male or female mice. In conclusion, when expressed in undifferentiated osteoblasts, Nlk is a negative regulator of skeletal homeostasis possibly by targeting signals that regulate osteoclastogenesis and bone resorption.
© 2014 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24664870      PMCID: PMC4117815          DOI: 10.1002/jcp.24625

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  45 in total

1.  Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors.

Authors:  Stephen J Rodda; Andrew P McMahon
Journal:  Development       Date:  2006-07-19       Impact factor: 6.868

Review 2.  Bone morphogenetic proteins and their antagonists.

Authors:  Elisabetta Gazzerro; Ernesto Canalis
Journal:  Rev Endocr Metab Disord       Date:  2006-06       Impact factor: 6.514

3.  Different thermostabilities of FLP and Cre recombinases: implications for applied site-specific recombination.

Authors:  F Buchholz; L Ringrose; P O Angrand; F Rossi; A F Stewart
Journal:  Nucleic Acids Res       Date:  1996-11-01       Impact factor: 16.971

4.  Complementation mapping of skeletal and central nervous system abnormalities in mice of the piebald deletion complex.

Authors:  T P O'Brien; D L Metallinos; H Chen; M K Shin; S M Tilghman
Journal:  Genetics       Date:  1996-05       Impact factor: 4.562

5.  Rapid confirmation of gene targeting in embryonic stem cells using two long-range PCR techniques.

Authors:  J M Lay; L Friis-Hansen; P J Gillespie; L C Samuelson
Journal:  Transgenic Res       Date:  1998-03       Impact factor: 2.788

6.  Notch 1 overexpression inhibits osteoblastogenesis by suppressing Wnt/beta-catenin but not bone morphogenetic protein signaling.

Authors:  Valerie Deregowski; Elisabetta Gazzerro; Leah Priest; Sheila Rydziel; Ernesto Canalis
Journal:  J Biol Chem       Date:  2006-01-06       Impact factor: 5.157

7.  A histone lysine methyltransferase activated by non-canonical Wnt signalling suppresses PPAR-gamma transactivation.

Authors:  Ichiro Takada; Masatomo Mihara; Miyuki Suzawa; Fumiaki Ohtake; Shinji Kobayashi; Mamoru Igarashi; Min-Young Youn; Ken-ichi Takeyama; Takashi Nakamura; Yoshihiro Mezaki; Shinichiro Takezawa; Yoshiko Yogiashi; Hirochika Kitagawa; Gen Yamada; Shinji Takada; Yasuhiro Minami; Hiroshi Shibuya; Kunihiro Matsumoto; Shigeaki Kato
Journal:  Nat Cell Biol       Date:  2007-10-21       Impact factor: 28.824

8.  Age-related changes in trabecular architecture differ in female and male C57BL/6J mice.

Authors:  Vaida Glatt; Ernesto Canalis; Lisa Stadmeyer; Mary L Bouxsein
Journal:  J Bone Miner Res       Date:  2007-08       Impact factor: 6.741

9.  Drosophila Nemo antagonizes BMP signaling by phosphorylation of Mad and inhibition of its nuclear accumulation.

Authors:  Yi Arial Zeng; Maryam Rahnama; Simon Wang; Worlanyo Sosu-Sedzorme; Esther M Verheyen
Journal:  Development       Date:  2007-06       Impact factor: 6.868

Review 10.  Transcriptional regulation of osteoblasts.

Authors:  Renny T Franceschi; Chunxi Ge; Guozhi Xiao; Hernan Roca; Di Jiang
Journal:  Ann N Y Acad Sci       Date:  2007-11       Impact factor: 5.691

View more
  5 in total

1.  An antibody to Notch3 reverses the skeletal phenotype of lateral meningocele syndrome in male mice.

Authors:  Jungeun Yu; Christian W Siebel; Lauren Schilling; Ernesto Canalis
Journal:  J Cell Physiol       Date:  2019-06-12       Impact factor: 6.384

2.  Loss of Nmp4 optimizes osteogenic metabolism and secretion to enhance bone quality.

Authors:  Yu Shao; Emily Wichern; Paul J Childress; Michele Adaway; Jagannath Misra; Angela Klunk; David B Burr; Ronald C Wek; Amber L Mosley; Yunlong Liu; Alexander G Robling; Nickolay Brustovetsky; James Hamilton; Kylie Jacobs; Deepak Vashishth; Keith R Stayrook; Matthew R Allen; Joseph M Wallace; Joseph P Bidwell
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-01-15       Impact factor: 4.310

3.  Parathyroid hormone inhibits Notch signaling in osteoblasts and osteocytes.

Authors:  Stefano Zanotti; Ernesto Canalis
Journal:  Bone       Date:  2017-07-01       Impact factor: 4.398

Review 4.  Nemo-Like Kinase in Development and Diseases: Insights from Mouse Studies.

Authors:  Renée Daams; Ramin Massoumi
Journal:  Int J Mol Sci       Date:  2020-12-02       Impact factor: 5.923

5.  Microglia regulate brain progranulin levels through the endocytosis/lysosomal pathway.

Authors:  Tingting Dong; Leon Tejwani; Youngseob Jung; Hiroshi Kokubu; Kimberly Luttik; Terri M Driessen; Janghoo Lim
Journal:  JCI Insight       Date:  2021-11-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.